WCBA
MDT icon

Weaver C. Barksdale & Associates’s Medtronic MDT Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$622K Buy
7,176
+1,314
+22% +$126K 0.59% 61
2025
Q4 		$563K Sell
5,862
-7,113
-55% -$691K 0.59% 62
2025
Q3 		$1.24M Sell
12,975
-661
-5% -$60.8K 1.19% 46
2025
Q2 		$1.19M Sell
13,636
-118
-0.9% -$10K 1.14% 49
2025
Q1 		$1.24M Sell
13,754
-264
-2% -$23.6K 1.19% 48
2024
Q4 		$1.12M Sell
14,018
-280
-2% -$24.2K 1.07% 53
2024
Q3 		$1.29M Sell
14,298
-441
-3% -$37.1K 1.16% 51
2024
Q2 		$1.16M Sell
14,739
-237
-2% -$19.4K 1.1% 51
2024
Q1 		$1.3M Sell
14,976
-103
-0.7% -$8.79K 1.2% 50
2023
Q4 		$1.24M Sell
15,079
-3,188
-17% -$243K 1.21% 50
2023
Q3 		$1.43M Buy
18,267
+3,914
+27% +$328K 1.22% 50
2023
Q2 		$1.26M Sell
14,353
-828
-5% -$71.3K 1.25% 51
2023
Q1 		$1.22M Sell
15,181
-691
-4% -$56.3K 1.14% 55
2022
Q4 		$1.23M Buy
15,872
+355
+2% +$28.8K 1.09% 57
2022
Q3 		$1.25M Buy
15,517
+355
+2% +$31.9K 1.26% 53
2022
Q2 		$1.36M Buy
15,162
+1,003
+7% +$102K 1.27% 54
2022
Q1 		$1.57M Buy
14,159
+184
+1% +$19.4K 1.4% 50
2021
Q4 		$1.45M Buy
+13,975
New +$1.62M 1.31% 52
2017
Q4 		$1.3M Buy
16,143
+555
+4% +$44.4K 1.37% 42
2017
Q3 		$1.21M Buy
15,588
+4,755
+44% +$395K 1.35% 44
2017
Q2 		$961K Hold
10,833
– – 1.12% 50
2017
Q1 		$873K Sell
10,833
-829
-7% -$64.8K 1.03% 54
2016
Q4 		$831K Buy
+11,662
New +$916K 1.34% 50

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Weaver C. Barksdale & Associates's MDT Position: Q1 2026 in Review

Weaver C. Barksdale & Associates increased its Medtronic (MDT) stake by 22% in Q1 2026, buying an estimated $126K and bringing the position to 7,176 shares worth $622K. The position accounts for 0.59% of the portfolio, ranked #61.

Weaver C. Barksdale & Associates first reported a position in MDT in Q4 2016 and has held it in 23 quarters since. The position peaked at $1.57M in Q1 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Weaver C. Barksdale & Associates held 7,176 shares of Medtronic worth $622K as of Q1 2026.
  • Weaver C. Barksdale & Associates bought 1,314 Medtronic shares in Q1 2026, an estimated $126K.
  • Medtronic made up 0.59% of Weaver C. Barksdale & Associates's portfolio in Q1 2026, its #61 holding.
  • Weaver C. Barksdale & Associates first reported a position in Medtronic in Q4 2016 and has held it in 23 quarters since.
  • Weaver C. Barksdale & Associates's Medtronic position peaked at $1.57M in Q1 2022.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Weaver C. Barksdale & Associates's 13F filing for Q1 2026, filed 14 May 2026.